TRIPOD (TRoglitazone In the Prevention Of Diabetes): A randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus

Controlled Clinical Trials

Volumn 19, Issue 2, 1998, Pages 217-231

  Azen, Stanley P ^a   Peters, Ruth K ^a   Berkowitz, Kathleen ^a   Kjos, Siri ^a   Xiang, Anny ^a   Buchanan, Thomas A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Clinical trial design; Diabetes; Phase III study; Prevention trial

Indexed keywords

PLACEBO; TROGLITAZONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CAROTID STENOSIS; CHROMANS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; MIDDLE AGED; PREGNANCY; PREGNANCY IN DIABETICS; QUALITY OF LIFE; RECURRENCE; RISK FACTORS; THIAZOLES; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 0032053701     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(97)00151-7     Document Type: Article

References (30)

1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;29:1039-1057.
2. Kjos SL, Peters RK, Xiang Aet al. Predicting future diabetes in Latina women with gestational diabetes. utility of early postpartum glucose tolerance testing Diabetes. 44:1995;586-591.
3. Buchanan TA, Metzger BE, Freinkel Net al. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 162:1990;1008-1014.
4. Saad MF, Knowler WC, Pettit DJet al. The natural history of impaired glucose tolerance in Pima Indians. N Engl J Med. 319:1988;1500-1505.
5. DeFronzo RA, Bonadonna RC, Ferrannini E Pathogenesis of NIDDM. a balanced overview Diabetes Care. 15:1992;318-368.
6. Ward WK, Johnston CLW, Beard JCet al. Abnormalities of islet B-cell function, insulin action and fat distribution in women with a history of gestational diabetes. relation to obesity J Clin Endocrin Metab. 61:1985;1039-1045.
7. Ward WK, Johnston CLW, Beard JCet al. Insulin resistance and impaired insulin secretion in subjects with a history of gestational diabetes mellitus. Diabetes. 34:1985;861-869.
8. Ryan EA, Imes S, Liu Det al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 44:1995;506-512.
9. Peters RK, Kjos SL, Xiang Aet al. Long-term diabetogenic effect of a single pregnancy in women with prior gestational mellitus. Lancet. 347:1996;227-230.
10. Kramer FM, Jeffry RW, Forster JLet al. Long-term follow-up of behavioral treatment for obesity. patterns of weight regain among men and women Int J Obesity. 13:1989;123-136.
11. Snow-Harter C, Bouxsein ML, Lewis BTet al. Effects of resistance and endurance exercise on bone mineral status of young women. a randomized exercise intervention trial J Bone Min Res. 2:1992;761-769.
12. Eriksson KF, Lingrade F Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia. 34:1991;891-898.
13. DeFronzo RA, Goodman AM, and the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:541-549.
14. Widen EJM, Eriksson JG, Groop LC Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes. 41:1992;354-358.
15. Suter SL, Nolan JJ, Wallace Pet al. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 15:1992;193-203.
16. Nolan JJ, Ludvik B, Beerdsen Pet al. Improvement in glucose tolerance and insulin resistance in obese subjects with troglitazone. N Engl J Med. 331:1994;1188-1193.
17. Berkowitz K, Peters R, Kjos SLet al. Effect of troglitazone on insulin sensitivity and pancreatic B-cell function in women at high risk for non-insulin-dependent diabetes mellitus. Diabetes. 45:1996;1572-1579.
18. WHO Expert Committee on Diabetes Mellitus, Second Report. Technical Report Series 646. Geneva: World Health Organization; 1980.
19. Bergman RN, Phillips LS, Cobelli C Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and beta-cell sensitivity from the response to intravenous glucose. J Clin Invest. 68:1981;1456-1467.
20. Bergman RN, Ider YZ, Bowden CRet al. Quantitative estimation of insulin sensitivity. Am J Physiol. 236:1979;E667-677.
21. Tofolo GR, Bergman RN, Finegood DTet al. Quantitative estimation of B-cell sensitivity to glucose in the intact organism. a minimal model of insulin kinetics in the dog Diabetes. 29:1980;979-990.
22. O'Leary HG, Zaccaro D, Haffner Set al. for the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Insulin sensitivity and atherosclerosis. Circulation. 93:1996;1809-1817.
23. Young W, Gofman JW, Tandy Ret al. The quantitation of atherosclerosis. III. The extent of correlation of degrees of atherosclerosis within and between the coronary and cerebral vascular beds. Am J Cardiol. 6:1960;300-308.
24. Sternby NH Atherosclerosis in a defined population. an autopsy survey in Malmo, Sweden Acta Pathol Microbiol Scand. 194:1968;1-216.
25. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute; 1993;3:21-22.
26. Jacobson AM, De Groot M, Samson JA The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 17:1994;267-274.
27. Willett WC, Sampson L, Stampfer MJet al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 122:1985;51-65.
28. Willett WC, Stamfer JM, Underwood BAet al. Validation of a dietary questionnaire with plasma carotenoid and alpha-tocopherol levels. Am J Clin Nutr. 28:1983;631-639.
29. Calfas KJ, Long B, Sallis JFet al. A controlled trial of physician counselling to promote adoption of physical activity. Prev Med. 25:1996;225-233.
30. Haffner SM, Stern MP, Mitchell BDet al. Incidence of type II diabetes in Mexican-Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes. 39:1990;283-288.